ID: ALA225612

Max Phase: Preclinical

Molecular Formula: C14H9BrClNO3

Molecular Weight: 354.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cc(Cl)ccc1C(=O)O)c1cccc(Br)c1

Standard InChI:  InChI=1S/C14H9BrClNO3/c15-9-3-1-2-8(6-9)13(18)17-12-7-10(16)4-5-11(12)14(19)20/h1-7H,(H,17,18)(H,19,20)

Standard InChI Key:  NKUSVNRZDILGSG-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate receptor ionotropic kainate 1 340 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 354.59Molecular Weight (Monoisotopic): 352.9454AlogP: 4.05#Rotatable Bonds: 3
Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.55CX Basic pKa: CX LogP: 4.75CX LogD: 1.39
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.87Np Likeness Score: -1.55

References

1. Valgeirsson J, Nielsen EO, Peters D, Mathiesen C, Kristensen AS, Madsen U..  (2004)  Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5.,  47  (27): [PMID:15615543] [10.1021/jm030638w]

Source